- The trend backdrop is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
JOCIL
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Jocil Limited · Basic Materials · Specialty Chemicals
Latest close
147.0 INR
1.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 9.9% above the Trend Line and sits at 66.5% of its 52-week range. The latest completed week returned 1.9%, after a -0.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 49/100.
Setup score
49
out of 100
Latest Close
147.0 INR
7 Aug 2026
1W Return
1.9%
latest completed week
4W Return
-0.7%
short-term follow-through
12W Return
8.8%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.9%
Latest completed week; four-week move -0.7%.
Indicator stack
35/57
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
49/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.9% above the Trend Line and sits at 66.5% of its 52-week range. The latest completed week returned 1.9%, after a -0.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5212-week average 0.32
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.52Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.7% over four weeks, 8.8% over 12 weeks, and -9.8% over one year. The current trend has remained active for 6 consecutive weeks.
Performance by holding period
Active trend streak6 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.57Latest activity-pressure read.
Pressure change-42.4%Four-week change in activity pressure.
Leadership4.64Latest relative-leadership reading.
RS change-25.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength56/100Blend of value, momentum, and quality. Underlying universe rank 45; rank 1 is best.
Value52/100Relative valuation strength. Underlying universe rank 49; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum54/100Medium-term price momentum. Underlying universe rank 47; rank 1 is best.
Growth52/100Revenue and earnings growth. Underlying universe rank 49; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework66/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 15.7x Price divided by trailing earnings.
- Price / sales
- 0.1x Market value relative to trailing revenue.
- EV / EBITDA
- 6.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -0.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 17.0% Gross profit retained from each unit of revenue.
- Operating margin
- 1.0% Operating profit retained from revenue.
- Free-cash-flow margin
- -0.0% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 20.6% Latest one-year revenue growth.
- EPS growth
- 713.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -124.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment49/100
Weighted news tone is neutral across 5 relevant articles.
1 positive · 3 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.1%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+10.4%Week of 10 Apr.
Worst week-9.5%Week of 27 Mar.
Latest week+1.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains9
Flat weeks0
Modest losses7
Sharp losses4
Recent vol3.2%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank- / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape48/100
Trend, activity pressure, participation, and risk combine to a 48/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 11/12.
Activity pressure 0.52; No reversal markers Factors52/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 44; Buyback Yield rank 12 SVQF66/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 537.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment49/100Weighted news tone is neutral across 5 relevant articles.
Jocil Ltd is Rated Hold by MarketsMOJO Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 147.0 INR | 1.9% | 133.7 INR | 173.8 INR | 0.57 | 4.64 | 37.2K | On |
| 31 Jul 2026 | 144.3 INR | -2.4% | 133.5 INR | 174.0 INR | 0.73 | 3.25 | 7.9K | On |
| 24 Jul 2026 | 147.9 INR | 3.6% | 133.5 INR | 174.3 INR | 0.89 | 8.41 | 7.8K | On |
| 17 Jul 2026 | 142.8 INR | -3.6% | 133.3 INR | 174.6 INR | 0.92 | 2.07 | 12.7K | On |
| 10 Jul 2026 | 148.1 INR | 2.4% | 133.4 INR | 175.0 INR | 0.99 | 6.20 | 7.2K | On |
| 3 Jul 2026 | 144.6 INR | -1.7% | 133.3 INR | 175.2 INR | 1.00 | 3.28 | 1.6K | On |
| 26 Jun 2026 | 147.1 INR | -3.4% | 133.5 INR | 175.4 INR | 1.04 | 5.86 | 0 | Off |
| 19 Jun 2026 | 152.2 INR | 0.7% | 133.7 INR | 175.7 INR | 1.17 | 9.63 | 2.6K | Off |
| 12 Jun 2026 | 151.1 INR | 0.3% | 133.5 INR | 175.9 INR | 1.07 | 10.66 | 2.6K | Off |
| 5 Jun 2026 | 150.6 INR | 2.1% | 133.5 INR | 176.1 INR | 0.98 | 11.49 | 3.2K | Off |
| 29 May 2026 | 147.5 INR | 8.6% | 133.5 INR | 176.4 INR | 0.97 | 8.32 | 343.9K | Off |
| 22 May 2026 | 135.8 INR | 0.5% | 133.8 INR | 176.6 INR | 0.72 | -1.12 | 12.0K | Off |
| 15 May 2026 | 135.1 INR | -2.2% | 134.3 INR | 176.9 INR | 0.63 | -1.59 | 6.1K | Off |
| 8 May 2026 | 138.1 INR | 7.9% | 134.7 INR | 177.2 INR | 0.41 | -1.86 | 29.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.